Future-Focused Strategy | Delve into ResMed's expansion beyond sleep apnea, leveraging wearable technology and addressing COMISA, while navigating potential growth slowdowns in FY26-27 |
Market Position Shift | Learn how ResMed capitalized on competitor issues, but may face stabilizing market share as Philips recovers, with analyst price targets ranging from $247 to $280 |
Innovation Drives Growth | Explore ResMed's success in masks and devices, including the AirSense 11, driving market share gains despite recent challenges in the Devices segment |
Sleep Tech Dominance | ResMed leads in sleep apnea and respiratory care, with strong financial health and consistent dividend growth, but faces evolving market dynamics |

Metrics to compare | RMD | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship RelationshipRMDPeersSector | |
|---|---|---|---|---|
P/E Ratio | 18.2x | 16.0x | −0.5x | |
PEG Ratio | 1.11 | 0.37 | 0.00 | |
Price / Book | 4.3x | 1.6x | 2.6x | |
Price / LTM Sales | 5.0x | 1.4x | 3.1x | |
Upside (Analyst Target) | 50.1% | 26.1% | 53.6% | |
Fair Value Upside | Unlock | 34.0% | 7.5% | Unlock |
ResMed Inc. develops, manufactures, distributes, and markets medical devices and cloud-based software applications to diagnose, treat, and manage respiratory disorders in the United States and internationally. The company operates in two segments, Sleep and Breathing Health, and Residential Care Software. It offers sleep recorders for the diagnosis and titration of sleep apnea in sleep clinics, hospitals, and at home, including ApneaLink Air, a portable diagnostic device that measures oximetry, respiratory effort, pulse, nasal flow, and snoring; NightOwl, a portable, cloud-connected, and disposable diagnostic device that measures AHI based on derived peripheral arterial tone, actigraphy, and oximetry; and EasyCare Tx, a sleep lab solution. The company also provides AirView, a cloud-based system that enables remote monitoring and changing of patients’ device settings; myAir, a personalized therapy management application for patients with sleep apnea that provides support, education, and troubleshooting tools for increased patient engagement and improved compliance; and connectivity module which provides a cellular connection between compatible ventilation devices and AirView system. In addition, the company offers Brightree solutions which are solutions and services for organizations in home medical equipment and pharmacy, orthotic and prosthetic, and home infusion; HEALTHCAREfirst solutions that offers electronic health record, software, billing and coding services, and advanced analytics that enables home health and hospice agencies to optimize clinical, financial and administrative processes; MatrixCare EHR software as a service solutions used by skilled nursing and senior living providers, life plan communities, and home health and hospice sectors; and MEDIFOX DAN software solutions that is used by residential care providers, such as home health and nursing home providers. ResMed Inc. was founded in 1989 and is headquartered in San Diego, California.